VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

COSTEM 2022 | The importance of bridging therapy in follicular and mantle cell lymphoma

Nicolaus Kröger, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, briefly comments on the importance of bridging CAR-T therapy in relapsed/refractory (R/R) patients with mantle cell lymphoma (MCL) and follicular lymphoma (FL). This interview took place at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter